Target intelligence / Profile preview

Thiol and amine groups in skin proteins and biomolecules (None)

Target
None
Molecular classification
Other
01

Overview

Thiol and amine groups in skin proteins and biomolecules serve as the primary nucleophilic targets for electrophilic chemicals, a process central to the development of skin sensitization (OECD, 2012). These functional groups are predominantly found on cysteine and lysine residues within abundant skin proteins such as keratin and human serum albumin (Gerberick et al., 2007). The covalent modification of these groups by haptens—small, reactive molecules—forms immunogenic hapten-protein complexes, which is the first key event in the Adverse Outcome Pathway (AOP) for allergic contact dermatitis (Aptula et al., 2005). While these groups are not therapeutic targets in the conventional sense, their reactivity is a critical parameter in the safety evaluation of topical pharmaceuticals and cosmetic ingredients (Karlberg et al., 2008). Understanding the kinetics and specificity of these interactions is essential for predicting the allergenic potential of new chemical entities using in chemico methods like the Direct Peptide Reactivity Assay (DPRA) (Natsch et al., 2013). These interactions can lead to the activation of the innate immune system and the subsequent priming of T-cells, resulting in a delayed-type hypersensitivity reaction upon re-exposure. Monitoring the depletion of synthetic peptides containing these groups is a standard regulatory approach for assessing skin sensitization risk. Beyond toxicology, these groups are also involved in the structural integrity of the skin barrier through the formation of disulfide bonds in the cornified envelope.

Other names
Skin protein nucleophilesNucleophilic amino acid residuesCysteine and lysine residues in skin proteinsProtein-reactive functional groups
02

Mechanism of action

Covalent binding (haptenization) to nucleophilic sites on skin proteins, leading to the formation of complete antigens and subsequent T-cell mediated immune responses.

03

Biological functions

Structural integrityEnzymatic catalysisBufferingOther
04

Disease associations

Allergic contact dermatitisSkin sensitizationInflammationOther
05

Safety considerations

Skin sensitizationAllergic contact dermatitisType IV hypersensitivityImmunotoxicity
06

Interacting drugs

1-Chloro-2,4-dinitrobenzene (DNCB)

5 more in the full profile.

07

Biomarkers

Cysteine depletionLysine depletionProtein-hapten adductsDirect Peptide Reactivity Assay (DPRA) reactivity

Beyond the preview

Go deeper on Thiol and amine groups in skin proteins and biomolecules (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Thiol and amine groups in skin proteins and biomolecules (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call